This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global exosome research market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the exosome research market. The secondary sources used for this study include the International Chromosome and Genome Society (ICGS), the National Human Genome Research Institute (NHGRI), the Asia Pacific Society of Human Genetics (APSHG), Genetics Society of America (GSA), the European Society of Human Genetics (ESHG), Centers for Common Disease Genomics (CDDG), Center for Cellular and Molecular Biology (CCMB) (India), the Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food & Drug Administration (US FDA). Scientist Magazine, ScienceDirect, research journals, corporate filings such as annual reports, SEC filings, investor presentations, financial statements, press releases, trade, business, professional associations, and others are also pivotal sources. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Comprehensive primary research was undertaken following an initial assessment of the global exosome research market landscape through secondary research. This involved conducting in-depth interviews with market experts from the demand side, including stakeholders from pharmaceutical & biotechnology firms, CROs, CMOs, and academic and research institutions. Additionally, interviews were held with key supply-side participants, such as C-suite and senior executives, product managers, and marketing and sales leaders from prominent manufacturers, distributors, and channel partners. The research covered six major geographical regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while 30% involved demand-side experts. Data collection methods included structured questionnaires, email correspondence, online surveys, personal interviews, and telephonic discussions to understand the market dynamics comprehensively.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both bottom-up and top-down approaches were used to estimate and validate the total size of the exosome research market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
-
A list of the major global players operating in the exosome research market was generated.
-
The revenues generated from their exosome research product have been determined through annual reports and secondary sources (including paid databases)
-
The products were mapped according to the segments of the market. Percentage shares and splits were determined based on the revenue contributed to each segment; this was verified using secondary sources and by industry experts.
-
All assumptions, approaches, and individual shares/revenue estimates were validated through expert interviews.
Global Exosome Research Market Size: Bottom-up and Top-down Approach
Data Triangulation
After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Exosomes are biomembrane-like vesicles containing protein, miRNA, and lipids that can be delivered to the extracellular milieu (ECM). Exosomes are naturally produced within the body and could be utilized in cell-to-cell communication, molecular therapy for cancer treatment, and the diagnosis of skeletal disorders. They have several advantages in cell-based treatment, which has brought attention to R&D in this field.
Stakeholders
-
Manufacturers and distributors of exosome research products
-
Pharmaceutical and biotechnology companies
-
Contract research organizations (CROs)
-
Contract development & manufacturing organizations (CDMOs)
-
Market research and consulting firms
-
R&D centers
-
Academic & research institutes
-
Regulatory agencies
-
Health insurers and payers
-
Venture capitalists
-
Government organizations
-
Industry associations & professional societies
-
Private & government funding organizations
Report Objectives
-
To define, describe, and forecast the exosome research market based on offering, indication, application, manufacturing service, end user, and region
-
To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
-
To strategically analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the exosome research market
-
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
-
To forecast the size of the market segments concerning five main regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
-
To profile the key players in the global exosome research market and comprehensively analyze their product portfolios, market positions, and core competencies
-
To track and analyze competitive developments such as product approvals and launches, expansions, agreements, and collaborations in the exosome research market
-
To benchmark players within the exosome research market using the company evaluation matrix framework, which analyzes market players based on various parameters within the broad categories of business and service strategy
Growth opportunities and latent adjacency in Exosome Research Market